Attention: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. iDrugs24.com is not responsible for any damage to your health as the result of self treatment. # On 2025-Jul-06 aproximate price on "TAMOXIFEN-TEVA TBL 20MG N30 N100" in Riga city, Latvia is:
Maximum allowed state defined price ( from ZVA webpage) Euro: |  | Recheck |
Reģ. Nr.: 03-0191
Vendor, principal: Teva Pharmaceutical. TAMOXIFEN-TEVA TBL 20MG N30 N100 is compensated medicine in Latvia.
Prescription drug (℞)
Similar or the same name medicines, products list * |
Medicament / Item title |
Prices |
Pharmacies chain |
TAMOXIFEN EBEWE 20 MG TABLETĖS N30 |
6.02€, Jul.2025 |
Gintarinė vaistinė nvaistine.lt (Lithuania) Phone: 880010008 |
TAMOXIFEN-EBEWE 20 MG TABLETĖS N30 (Ebewe Pharma) |
6.02€, Jun.2025 |
100 metų vaistinė (Lithuania) Phone: +37038159292 |
TAMOXIFEN EBEWE 20MG TABLETĖS N30, Tamoksifenas Rx (TAMOXIFEN EBEWE) |
6.02€, Mar.2025 |
Eurovaistine LT (Lithuania) Phone: +370852602200  |
TAMOXIFEN MYLAN 20 MG TABLETĖS N30 (Lex ano, UAB) |
6.03€, Jun.2025 |
100 metų vaistinė (Lithuania) Phone: +37038159292 |
TAMOXIFEN "EBEWE" TBL 20MG N30, tamoksifeen Rx |
9.88€, Jun.2025 |
Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844 |
TAMOXIFEN-EBEWE TBL 20MG N30 |
9.88€, Jul.2025 |
Valga selveri apteek. Apotheka.ee (Estonia) Phone: +3727661766  |
TAMOXIFEN-EBEWE TBL 20MG N30 |
9.88€, Jul.2025 |
Valga südameapteek (Estonia) Phone: +3727668005 |
* This table was compiled fully automatically, independently from any advertisers, transparently and without any modification relaying the open offers available on the mentioned dates.Only the distribution of over-the-counter remedies through the website is permitted in Latvia in accordance with national laws and regulations.
[*1]
DDD. Information source: WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health
Back
|